Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Viral RNA genome synthesis” is the process by which RNA viruses direct the generation of progeny viral RNA genomes within infected host cells. This is catalyzed primarily by virally-encoded RNA-dependent RNA polymerases (RdRp), often operating as part of a multi-protein replicase complex, which may also include viral helicases and other cofactors[1][2]. The process includes synthesis of full-length genomes, antigenomic copies, and subgenomic mRNAs required for virion assembly and propagation. RdRp and associated proteins are the main molecular drug targets within this process[1][2]. Therapeutic interventions focus on inhibiting the activity of RdRp or its auxiliary factors to halt viral replication.
Inhibition of RNA-dependent RNA polymerase activity (blocks RNA chain elongation or initiation); Promote error catastrophe (increased error rate leading to nonviable viral genomes); Chain termination (prevents completion of RNA strand synthesis)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral RNA genome synthesis.